These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 22945591)

  • 41. Overview of hyperuricaemia and gout.
    Masseoud D; Rott K; Liu-Bryan R; Agudelo C
    Curr Pharm Des; 2005; 11(32):4117-24. PubMed ID: 16375732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patients with gout can be cured in primary care.
    Rees F; Doherty M
    Practitioner; 2014 Dec; 258(1777):15-9, 2. PubMed ID: 25603588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pathological mechanisms of gouty arthritis].
    Akahoshi T
    Nihon Rinsho; 2008 Apr; 66(4):705-10. PubMed ID: 18409519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transmembrane TNF-α is sufficient for articular inflammation and hypernociception in a mouse model of gout.
    Amaral FA; Bastos LF; Oliveira TH; Dias AC; Oliveira VL; Tavares LD; Costa VV; Galvão I; Soriani FM; Szymkowski DE; Ryffel B; Souza DG; Teixeira MM
    Eur J Immunol; 2016 Jan; 46(1):204-11. PubMed ID: 26449770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monosodium urate crystals in asymptomatic knee joints.
    Gordon TP; Bertouch JV; Walsh BR; Brooks PM
    J Rheumatol; 1982; 9(6):967-9. PubMed ID: 7161792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical features of gout.
    Grassi W; De Angelis R
    Reumatismo; 2012 Jan; 63(4):238-45. PubMed ID: 22303530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A mouse model of MSU-induced acute inflammation
    Mariotte A; De Cauwer A; Po C; Abou-Faycal C; Pichot A; Paul N; Aouadi I; Carapito R; Frisch B; Macquin C; Chatelus E; Sibilia J; Armspach JP; Bahram S; Georgel P
    Theranostics; 2020; 10(5):2158-2171. PubMed ID: 32104502
    [No Abstract]   [Full Text] [Related]  

  • 48. Gout: a disease involved with complicated immunoinflammatory responses: a narrative review.
    Wu M; Tian Y; Wang Q; Guo C
    Clin Rheumatol; 2020 Oct; 39(10):2849-2859. PubMed ID: 32382830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolism of crystals within the joint.
    Oliviero F; Scanu A; Punzi L
    Reumatismo; 2012 Jan; 63(4):221-9. PubMed ID: 22303528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Physiology and dynamics of uric acid in hyperuricemia].
    Takagi K; Nakamura T; Ueda T
    Nihon Rinsho; 2008 Apr; 66(4):669-74. PubMed ID: 18409512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities.
    Robinson PC; Horsburgh S
    Maturitas; 2014 Aug; 78(4):245-51. PubMed ID: 24880206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IL-17A neutralizing antibody regulates monosodium urate crystal-induced gouty inflammation.
    Raucci F; Iqbal AJ; Saviano A; Minosi P; Piccolo M; Irace C; Caso F; Scarpa R; Pieretti S; Mascolo N; Maione F
    Pharmacol Res; 2019 Sep; 147():104351. PubMed ID: 31315067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Uric acid transport and disease.
    So A; Thorens B
    J Clin Invest; 2010 Jun; 120(6):1791-9. PubMed ID: 20516647
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A quantitative study of the phagocytosis of urate crystals in the synovial fluid of asymptomatic joints of patients with gout.
    Pascual E; Jovaní V
    Br J Rheumatol; 1995 Aug; 34(8):724-6. PubMed ID: 7551655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Xanthine oxidoreductase and its inhibitors: relevance for gout.
    Day RO; Kamel B; Kannangara DR; Williams KM; Graham GG
    Clin Sci (Lond); 2016 Dec; 130(23):2167-2180. PubMed ID: 27798228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Melanocortin peptides inhibit urate crystal-induced activation of phagocytic cells.
    Capsoni F; Ongari AM; Reali E; Catania A
    Arthritis Res Ther; 2009; 11(5):R151. PubMed ID: 19814819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulation of Transcription Factor T-Bet as a Protective Strategy in Monosodium Urate-Induced Gouty Inflammation.
    Yang QB; He YL; Zhang QB; Mi QS; Zhou JG
    Front Immunol; 2019; 10():1199. PubMed ID: 31231373
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NALP3 inflammasome functional polymorphisms and gout susceptibility.
    Miao ZM; Zhao SH; Yan SL; Li CG; Wang YG; Meng DM; Zhou L; Mi QS
    Cell Cycle; 2009 Jan; 8(1):27-30. PubMed ID: 19106604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation.
    Liu-Bryan R; Pritzker K; Firestein GS; Terkeltaub R
    J Immunol; 2005 Apr; 174(8):5016-23. PubMed ID: 15814732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The "switch-off" mechanism of spontaneous resolution of acute gout attack.
    Marcolongo R; Calabria AA; Lalumera M; Gerli R; Alessandrini C; Cavallo G
    J Rheumatol; 1988 Jan; 15(1):101-9. PubMed ID: 2832599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.